Echt, Netherlands

Angela De Bruine-Paulus


Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Angela De Bruine-Paulus: A Pioneer in Proline-Specific Endoprotease Inventions**

Introduction

Angela De Bruine-Paulus is an accomplished inventor based in Echt, Netherlands. With a remarkable portfolio of three patents, Angela has made significant contributions in the field of biochemistry, particularly through her innovative work on proline-specific endoproteases.

Latest Patents

Among her latest patents, Angela's work on proline-specific endoproteases stands out. Her invention relates to a polypeptide exhibiting proline-specific endoprotease activity, which includes various amino acid substitutions aimed at enhancing its properties. Notably, one of her patents discusses a polypeptide that retains less than 70% residual activity when subjected to a temperature of 65°C for 15 minutes. This advancement is pivotal for applications in food and feed products, making her invention relevant in both industrial and nutritional contexts.

Career Highlights

Angela is affiliated with DSM IP Assets B.V., a leading company in the field of biotechnology. Her research contributions have helped the company innovate and maintain a competitive edge in the industry. Through her inventive spirit and dedication, Angela has solidified her reputation as an inspiring figure in scientific research and development.

Collaborations

Angela has collaborated with notable coworkers such as Jan Metske Van Der Laan and Peter Jozef Ida Van De Vondervoort. Their teamwork has fostered an environment of creativity and innovation, enabling significant advancements in their respective projects.

Conclusion

Angela De Bruine-Paulus exemplifies the spirit of innovation in her field. With her cutting-edge patents, she continues to inspire the next generation of inventors and scientists. Her work not only enhances our understanding of biochemistry but also has practical implications for various industries, marking her as a key figure in ongoing discussions about biotechnology advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…